<a href="https://laohu8.com/S/01013">Wai Chun</a> Bio-Technology Secures Loan Agreement to Support Business Expansion
Wai Chun Bio-Technology Limited announced that on 29 September 2022, its indirect non-wholly-owned subsidiary, Century-Light, entered into a loan agreement with a borrower ultimately controlled by Mr. Liu Weijie. The agreement was designed to support the borrower's development of factory facilities and acquisition of production machinery. The borrower, as well as Weifang Shengtai Pharmaceutical Co., Ltd., are both controlled by Mr. Liu, a long-standing business partner of the Group. All drawdowns under the loan agreement, along with the relevant interest payments, were fully settled by the borrower to Century-Light in May 2025. This transaction was classified under major and disclosable transactions and involved compliance considerations with Hong Kong's Listing Rules.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Chun Bio Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11954729), on December 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.